Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gaviscon Double Action versus placebo intragastric acid neutralisation study in healthy volunteers
2014-003158-15Phase 2Completed
- Sponsor
- Reckitt
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial comparing Gaviscon Double Action Liquid Sachets with Placebo liquid (2 arms). Primary endpoint: Mean percentage of time with intragastric pH at or above 4 over 0 to 30 minutes post-dose. Started Aug 2014; status: completed.
02
Drugs
Gaviscon Double Action
Beyond the preview
Go deeper on 2014-003158-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003158-15.